ARCHIVES

Phase II Imbruvica Trial Shows 47% of MCL Patients Alive at 27-Month Median Follow-up

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

ORI Finds Researcher Falsified Records

February 9, 1996

Cancer Prevention Grants Awarded To Five States, DC

June 30, 1989

NCI Using Three Methods To Encourage Grants In Programs

August 25, 1978

When Screening Mammography Meets Health Care Reform, Opinions Proliferate

February 4, 1994

Cancer Groups Fear Clinical Trials Coverage Will Not Be Implemented Across Exchanges

July 3, 2013

AACR President Kripke Calls For Dedicated Translational Research

March 11, 1994